Phase I studies of the novel carcinoembryonic antigen T-cell bispecific (CEA-CD3 TCB) antibody as a single agent and in combination with atezolizumab: Preliminary efficacy and safety in patients (pts) with metastatic colorectal cancer (mCRC) Meeting Abstract
| Authors: | Segal, N. H.; Saro, J.; Melero, I.; Ros, W.; Argiles, G.; Marabelle, A.; Rodriguez Ruiz, M. E.; Albanell, J.; Calvo, E.; Moreno, V.; Cleary, J. M.; Eder, J. P.; Karanikas, V.; Bouseida, S.; Sandoval, F.; Sabanes, D.; Sreckovic, S.; Hurwitz, H. I.; Paz-Ares, L.; Tabernero, J. |
| Abstract Title: | Phase I studies of the novel carcinoembryonic antigen T-cell bispecific (CEA-CD3 TCB) antibody as a single agent and in combination with atezolizumab: Preliminary efficacy and safety in patients (pts) with metastatic colorectal cancer (mCRC) |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx367.036 |
| Language: | English |
| ACCESSION: | WOS:000411324001061 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx367.036 |
| Notes: | Meeting Abstract: 403P -- Appears on page 134 of the abstract book -- Source: Wos |
